Quick Order Cart

Cat. No. ARG39312

DNAJC5 Knockout MES-OV Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Ovary

  • Disease:

    Ovarian serous cystadenocarcinoma

The DNAJC5 Knockout MES-OV Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population derived from the MES-OV human ovarian endometrioid carcinoma cell line, providing a loss-of-function model for DNAJC5 to study its roles in autophagy and exocytosis. DNAJC5 encodes CSP-alpha, a co-chaperone that facilitates HSC70-dependent SNARE complex assembly and autophagy, interacting with HSC70/HSPA8, LC3, and SNARE proteins. This model enables investigation of DNAJC5 in ovarian cancer, protein clearance, and stress responses, with applications in Western blotting, co-immunoprecipitation, autophagy flux assays, and drug screening for autophagy modulators.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    MES-OV

    Sex of Donor

    Female

    Age

    53 years

    Derived From Site

    Ascites

    Gene Name

    DNAJC5

    Gene Identifier

    NCBI Gene ID 80331

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    McCoy's 5A

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DNAJC5 Knockout MES-OV Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population derived from the MES-OV human ovarian endometrioid carcinoma cell line. This loss-of-function model disrupts the DNAJC5 gene, enabling functional studies of the encoded cysteine string protein alpha (CSP-alpha) in processes such as chaperone-assisted SNARE complex assembly and autophagy, without clonal selection bias.

MES-OV is an adherent epithelial cell line derived from a human ovarian endometrioid carcinoma, widely used as a model for ovarian cancer biology. The cells retain malignant epithelial features, including dysregulated signaling and altered stress responses, making them suitable for investigating tumor-intrinsic mechanisms. Incorporating a DNAJC5 knockout in this background allows examination of CSP-alpha??s role in ovarian cancer cell physiology, particularly under proteotoxic or autophagic challenge.

DNAJC5 encodes CSP-alpha, a co-chaperone for HSC70/HSPA8 that is regulated by PKA and HSF1 signaling and activated by cellular stress. CSP-alpha directly interacts with HSC70 and SNARE proteins Syntaxin-1, SNAP-25, and VAMP2 to facilitate synaptic vesicle exocytosis. Independently, it promotes autophagic clearance by recruiting LC3, p62/SQSTM1, and VCP/p97, coupling chaperone activity to degradation. These dual roles position DNAJC5 as a critical regulator of proteostasis and membrane trafficking.

In ovarian cancer, CSP-alpha??s functions in exocytosis and autophagy may influence tumor adaptation to stress, secretion of growth factors, and chemoresistance. Although DNAJC5 is primarily linked to CLN4 neurodegeneration, emerging evidence indicates that chaperone-mediated processes and autophagy contribute to ovarian tumor progression. By disrupting DNAJC5 in MES-OV cells, this model enables dissection of its potential tumor-modulatory roles, including effects on cell viability, autophagy flux, and SNARE-dependent secretion.

Researchers can utilize this knockout population for Western blotting, RT-qPCR, and autophagy flux assays with chloroquine treatment and LC3 puncta imaging. Co-immunoprecipitation with HSC70 or Syntaxin-1 can map altered protein interactions. It is also suitable for drug screens targeting autophagy modulators or investigating stress sensitization. Thus, these cells provide a versatile tool for studying CSP-alpha pathology in cancer and neurodegeneration. For further details, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)